Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
485.39
-11.11 (-2.24%)
At close: Jul 10, 2026, 4:00 PM EDT
486.50
+1.11 (0.23%)
After-hours: Jul 10, 2026, 7:54 PM EDT

Vertex Pharmaceuticals Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Trikafta and Kaftrio
10.39B10.29B10.19B9.81B9.50B9.29B8.94B8.63B
Trikafta and Kaftrio Growth
9.44%10.80%13.95%13.59%13.46%15.77%16.36%17.33%
Kalydeco
---112.40M225.20M350.50M475.50M499.20M
Kalydeco Growth
----77.48%-57.17%-35.00%-14.05%-12.31%
Orkambi
---44.20M107.20M203.50M326.00M392.60M
Orkambi Growth
----88.74%-77.47%-59.39%-36.17%-28.27%
Symdeko and Semkevi
---27.80M61.20M92.40M123.00M129.50M
Symdeko and Semkevi Growth
----78.53%-54.43%-36.63%-31.67%-42.72%

Revenue By Geography

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
United States
7.67B7.55B7.29B7.03B6.82B6.68B6.42B6.26B
United States Growth
12.50%12.92%13.58%12.27%10.75%10.67%8.37%7.47%
Europe
3.58B3.46B3.41B3.42B3.31B3.45B3.36B3.28B
Europe Growth
8.17%0.19%1.47%4.31%1.34%11.09%9.68%8.30%
Other
973.30M992.40M991.70M939.20M958.10M881.30M846.30M798.40M
Other Growth
1.59%12.61%17.18%17.64%26.18%22.44%26.86%22.36%

Revenue By Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Trikafta and Kaftrio
10.13B10.31B10.46B10.39B10.29B10.19B9.81B9.50B
Trikafta and Kaftrio Growth
-1.53%1.18%6.67%9.44%10.80%13.95%13.59%13.46%
Kalydeco
------112.40M225.20M
Kalydeco Growth
-------77.48%-57.17%
Orkambi
------44.20M107.20M
Orkambi Growth
-------88.74%-77.47%
Symdeko and Semkevi
------27.80M61.20M
Symdeko and Semkevi Growth
-------78.53%-54.43%

Revenue by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
United States
7.03B6.82B6.68B6.42B6.26B6.16B6.04B5.93B
United States Growth
12.27%10.75%10.67%8.37%7.47%7.35%5.98%5.21%
Europe
3.42B3.31B3.45B3.36B3.28B3.27B3.11B3.06B
Europe Growth
4.31%1.34%11.09%9.68%8.30%13.50%14.91%17.34%
Other
939.20M958.10M881.30M846.30M798.40M759.30M719.80M667.10M
Other Growth
17.64%26.18%22.44%26.86%22.36%28.11%36.87%45.31%

Operating Expense Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Research and Development
3.89B3.91B3.93B3.83B3.82B3.63B3.46B3.39B
Research and Development Growth
1.85%7.69%13.84%13.05%19.05%14.78%13.98%18.24%
Selling, General, and Administrative
1.85B1.75B1.64B1.57B1.52B1.46B1.46B1.35B
Selling, General, and Administrative Growth
21.90%19.72%12.91%16.52%22.60%28.83%40.67%32.41%
Acquired In-Process Research and Development
113.70M133.00M164.00M124.50M4.57B4.63B4.56B4.60B
Acquired In-Process Research and Development Growth
-97.51%-97.13%-96.40%-97.29%1,680.14%778.09%757.06%802.47%
Change in Value of Contingent Consideration
100.00K2.10M-2.20M1.80M-500.00K-49.60M-48.70M
Change in Value of Contingent Consideration Growth
-94.44%-------